Medical Journal - Houston, October 2007 Researchers at UTMB are trying to determine whether a drug available to heart patients, Digibind, can also be used to delay delivery to expectant mothers with severe preeclampsia. The article quotes Dr. George Saade, chief of maternal-fetal medicine, and Dr. Nicole Ruddock, the principal investigator, both of UTMB. (October issue not available online as of this posting.)